Walleye Capital LLC Makes New $3.78 Million Investment in Addus HomeCare Corporation $ADUS

Key Points

• Walleye Capital LLC acquired a new stake in Addus HomeCare Corporation, investing approximately $3.78 million by purchasing 38,233 shares in the first quarter.
• Analysts have positive outlooks for Addus HomeCare, with a consensus rating of "Buy" and a target price around $138.38.
• Insider transactions revealed that CEO R Dirk Allison sold 25,000 shares for nearly $2.87 million, reducing his ownership by 13.06%.

Walleye Capital LLC acquired a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 38,233 shares of the company's stock, valued at approximately $3,781,000. Walleye Capital LLC owned about 0.21% of Addus HomeCare at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. BI Asset Management Fondsmaeglerselskab A S bought a new position in Addus HomeCare during the 1st quarter worth approximately $41,000. Caitong International Asset Management Co. Ltd grew its position in shares of Addus HomeCare by 368.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company's stock worth $124,000 after buying an additional 987 shares during the last quarter. Bailard Inc. bought a new stake in shares of Addus HomeCare in the 1st quarter worth approximately $208,000. Heritage Family Offices LLP grew its position in shares of Addus HomeCare by 6.3% in the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after buying an additional 143 shares during the last quarter. Finally, Private Advisor Group LLC grew its position in shares of Addus HomeCare by 52.4% in the 1st quarter. Private Advisor Group LLC now owns 2,546 shares of the company's stock worth $252,000 after buying an additional 875 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Stock Performance

NASDAQ:ADUS traded down $0.15 during mid-day trading on Friday, hitting $115.17. 72,791 shares of the company traded hands, compared to its average volume of 196,587. The stock's fifty day moving average price is $112.06 and its 200-day moving average price is $107.01. Addus HomeCare Corporation has a one year low of $88.96 and a one year high of $136.72. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17. The firm has a market cap of $2.12 billion, a price-to-earnings ratio of 25.42, a price-to-earnings-growth ratio of 1.76 and a beta of 0.80.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.45 by $0.04. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The business had revenue of $349.44 million during the quarter, compared to analyst estimates of $345.71 million. During the same quarter in the previous year, the company posted $1.35 earnings per share. Addus HomeCare's revenue for the quarter was up 21.8% on a year-over-year basis. Research analysts anticipate that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ADUS. Barclays raised their target price on Addus HomeCare from $83.00 to $109.00 and gave the company an "underweight" rating in a research note on Tuesday, August 19th. Royal Bank Of Canada raised their target price on Addus HomeCare from $133.00 to $134.00 and gave the company an "outperform" rating in a research note on Friday, August 22nd. Wall Street Zen upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Sunday, June 29th. TD Cowen raised their target price on Addus HomeCare from $135.00 to $139.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Finally, JMP Securities reiterated a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a research note on Wednesday, July 16th. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Buy" and an average target price of $138.38.

Insider Activity

In other news, Director Veronica Hill-Milbourne sold 1,571 shares of the business's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total value of $180,555.03. Following the transaction, the director directly owned 5,067 shares in the company, valued at $582,350.31. The trade was a 23.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the business's stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total value of $2,873,750.00. Following the completion of the transaction, the chief executive officer owned 166,461 shares in the company, valued at $19,134,691.95. The trade was a 13.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 34,310 shares of company stock worth $3,958,375 over the last ninety days. Corporate insiders own 4.50% of the company's stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.